Douglas Lorne Arnold, MD, FRCP(C)

Citeret af

	Alle	Siden 2018
Henvisninger	50941	18565
h-index	116	60
i10-indeks	386	263

4200

2100

1050

3150

199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023167 149 174 233 308 292 452 535 714 821 1090 1131 1056 1189 1338 1209 1307 1287 1287 1364 1339 1668 1929 2185 2323 2652 2990 3094 3330 3549 4109 4046 339

Offentlig adgang

Se alle

89 artikler

34 artikler

tilgængelige

ikke tilgængelige

Baseret på krav i forbindelse med finansiering

Medforfattere

Sridar Narayanan, PhDAssistant Professor: Department of Neurology and Neurosurgery, McGill UniversityBekræftet mail på mcgill.ca
Amit Bar-OrProfessor, University of PennsylvaniaBekræftet mail på pennmedicine.upenn.edu
Paul M. MatthewsEdmond and Lily Safra Chair, Professor of Clinical Neurosciences, Imperial College LondonBekræftet mail på imperial.ac.uk
D. Louis CollinsProfessor of Biomedical Engineering and Neurology & Neurosurgery, McGill UniversityBekræftet mail på mcgill.ca
Nicola De StefanoProfessor of Neurology, Universtiy of Siena,Bekræftet mail på unisi.it
Gavin GiovannoniBarts and The London School of Medicine and DentistryBekræftet mail på giovannoni.net
Zografos CaramanosMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill UniversityBekræftet mail på mcgill.ca
Fernando CendesFull Professor, Department of Neurology, FCM, University of Campinas - UNICAMPBekræftet mail på unicamp.br
Jerry S Wolinsky, MDEmeritus Professor in Neurology, McGovern Medical School, UTHealth, The University of Texas HealthBekræftet mail på uth.tmc.edu
Jeffrey A CohenCleveland ClinicBekræftet mail på ccf.org
Robert J FoxMellen Center for Multiple Sclerosis, Cleveland ClinicBekræftet mail på ccf.org
eric shoubridgeProfessor, Human Genetics, McGill UniversityBekræftet mail på ericpc.mni.mcgill.ca
Li Min LiProfessor of Neurology, Faculty of Medical Sciences at University of CampinasBekræftet mail på fcm.unicamp.br
Bruce PikeCAIP Chair in Healthy Brain Aging, Head of Image Science, Professor - U of CalgaryBekræftet mail på ucalgary.ca
John G. SledSenior Scientist, Hospital for Sick Children / Professor, University of TorontoBekræftet mail på utoronto.ca
Robert A BrownUniversity of Calgary; Montreal Neurological Institute; ShadowLab Research Inc.Bekræftet mail på shadowlabresearch.com
Emmanuelle WaubantProfessor of Neurology and PediatricsBekræftet mail på ucsf.edu
Alasdair ColesUniversity of CambridgeBekræftet mail på medschl.cam.ac.uk
Carmela TartagliaAssociate Professor, University of TorontoBekræftet mail på uhn.ca
Massimo FilippiSan Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityBekræftet mail på hsr.it

Følg

Douglas Lorne Arnold, MD, FRCP(C)

James McGill Professor: Department of Neurology and Neurosurgery, Faculty of Medicine, McGill

Bekræftet mail på mcgill.ca - Startside

Magnetic Resonance Imaging Neurological Disorders Multiple Sclerosis Alzheimer's Disease


Titel Sortér efter henvisninger Sortér efter årstal Sortér efter titel	Citeret af Citeret af	År
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ... New England Journal of Medicine 358 (7), 676-688, 2008	2522	2008
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ... New England Journal of Medicine 367 (12), 1098-1107, 2012	1837	2012
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ... N Engl J Med 376 (3), 209-220, 2017	1506	2017
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ... N Engl J Med 376 (3), 221-234, 2017	1379	2017
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ... The lancet 380 (9856), 1829-1839, 2012	1131	2012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ... The Lancet 380 (9856), 1819-1828, 2012	1130	2012
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P ... Lancet 391 (10127), 1263-1273, 2018	720	2018
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy MC Preul, Z Caramanos, DL Collins, JG Villemure, R Leblanc, A Olivier, ... Nature medicine 2 (3), 1996	652	1996
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability N De Stefano, S Narayanan, GS Francis, R Arnaoutelis, MC Tartaglia, ... Archives of neurology 58 (1), 65-70, 2001	637	2001
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: Results of a longitudinal magnetic resonance spectroscopy study N De Stefano, PM Matthews, L Fu, S Narayanan, J Stanley, GS Francis, ... Brain 121 (Pt 8), 1469-1477, 1998	599	1998
Imaging axonal damage of normal-appearing white matter in multiple sclerosis L Fu, PM Matthews, N De Stefano, KJ Worsley, S Narayanan, GS Francis, ... Brain 121 (1), 103-113, 1998	590	1998
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ... Annals of neurology 63 (3), 395-400, 2008	563	2008
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR DL Arnold, PM Matthews, GK Radda Magnetic resonance in medicine 1 (3), 307-315, 1984	558	1984
Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region N Bernasconi, A Bernasconi, Z Caramanos, SB Antel, F Andermann, ... Brain 126 (2), 462-469, 2003	541	2003
Reversible decreases in N‐acetylaspartate after acute brain injury ND Stefano, PM Matthews, DL Arnold Magnetic Resonance in Medicine 34 (5), 721-727, 1995	525	1995
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging D Garcia-Lorenzo, S Francis, S Narayanan, DL Arnold, DL Collins Medical image analysis 17 (1), 1-18, 2013	407	2013
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study PA Calabresi, BC Kieseier, DL Arnold, LJ Balcer, A Boyko, J Pelletier, ... The Lancet Neurology 13 (7), 657-665, 2014	400	2014
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques DL Arnold, PM Matthews, GS Francis, J O'Connor, JP Antel Annals of Neurology: Official Journal of the American Neurological …, 1992	397	1992
Energetics of human muscle: exercise-induced ATP depletion DJ Taylor, P Styles, PM Matthews, DL Arnold, DG Gadian, P Bore, ... Magn Reson Med 3 (1), 44-54, 1986	391	1986
Chemical pathology of acute demyelinating lesions and its correlation with disability N De Stefano, PM Matthews, JP Antel, M Preul, G Francis, DL Arnold Annals of neurology 38 (6), 901-909, 1995	382	1995

Systemet kan ikke foretage handlingen nu. Prøv igen senere.

Artikler 1–20

Henvisninger pr. år

Dublerede henvisninger

Flettede henvisninger

Tilføj medforfattereMedforfattere

Følg

Citeret af

Medforfattere